STOCK TITAN

Director’s trust trims Stryker (NYSE: SYK) stake around $360

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Stryker Corporation director Ronda E. Stryker, through a revocable trust, reported a series of open-market sales of Stryker common stock on February 4–5, 2026. The revocable trust sold multiple blocks of shares at weighted average prices ranging from $358.005 to $368.635 per share, as detailed in the footnotes. After these transactions, the revocable trust held 2,207,331 Stryker shares, with additional indirect holdings of 13,578,805 shares by the L. Lee Stryker Trust and 37,600 shares by the 1988 William D. Johnston Trust, plus 560 shares held directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
STRYKER RONDA E

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/04/2026 S 14,437 D $358.509(1) 2,692,894(2) I By Revocable Trust
Common Stock 02/04/2026 S 14,673 D $359.483(3) 2,678,221 I By Revocable Trust
Common Stock 02/04/2026 S 40,363 D $360.414(4) 2,637,858 I By Revocable Trust
Common Stock 02/04/2026 S 25,220 D $361.385(5) 2,612,638 I By Revocable Trust
Common Stock 02/04/2026 S 30,067 D $362.689(6) 2,582,571 I By Revocable Trust
Common Stock 02/04/2026 S 20,395 D $363.496(7) 2,562,176 I By Revocable Trust
Common Stock 02/04/2026 S 61,956 D $364.681(8) 2,500,220 I By Revocable Trust
Common Stock 02/04/2026 S 29,110 D $365.571(9) 2,471,110 I By Revocable Trust
Common Stock 02/04/2026 S 4,836 D $366.563(10) 2,466,274 I By Revocable Trust
Common Stock 02/04/2026 S 6,783 D $367.91(11) 2,459,491 I By Revocable Trust
Common Stock 02/04/2026 S 2,160 D $368.556(12) 2,457,331 I By Revocable Trust
Common Stock 02/05/2026 S 4,239 D $361.495(13) 2,453,092 I By Revocable Trust
Common Stock 02/05/2026 S 68,688 D $362.416(14) 2,384,404 I By Revocable Trust
Common Stock 02/05/2026 S 61,199 D $363.341(15) 2,323,205 I By Revocable Trust
Common Stock 02/05/2026 S 34,607 D $364.285(16) 2,288,598 I By Revocable Trust
Common Stock 02/05/2026 S 51,774 D $365.257(17) 2,236,824 I By Revocable Trust
Common Stock 02/05/2026 S 23,151 D $366.35(18) 2,213,673 I By Revocable Trust
Common Stock 02/05/2026 S 6,342 D $366.985(19) 2,207,331 I By Revocable Trust
Common Stock 13,578,805 I By L. Lee Stryker Trust
Common Stock 37,600 I By 1988 William D. Johnston Trust
Common Stock 560 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $358.005 to $358.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
2. Includes 5,223 shares previously held directly which were transferred to the Revocable Trust on February 2, 2026.
3. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $359.01 to $360.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
4. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.01 to $361.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
5. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.01 to $362.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
6. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.09 to $363.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
7. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $363.09 to $364.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
8. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.09 to $365.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
9. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $365.14 to $366.09, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
10. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.115 to $366.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
11. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.37 to $368.315, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
12. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.47 to $368.635, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
13. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.79 to $361.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
14. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.79 to $362.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
15. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.79 to $363.785, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
16. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $363.79 to $364.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
17. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.79 to $365.785, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
18. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $365.79 to $366.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
19. The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.79 to $367.32, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Ronda E. Stryker 02/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SYK director Ronda E. Stryker report?

Ronda E. Stryker reported that a revocable trust associated with her sold multiple blocks of Stryker common stock on February 4–5, 2026. The sales were open-market transactions executed at various weighted average prices disclosed in the filing’s footnotes.

At what prices were the Stryker (SYK) shares sold in this Form 4?

The reported Stryker common stock sales occurred at weighted average prices between $358.005 and $368.635 per share. Each line item reflects a weighted average, with detailed price ranges for the underlying trades provided in the footnotes to the Form 4.

How many Stryker shares does the revocable trust hold after these sales?

After the reported February 4–5, 2026 transactions, the revocable trust held 2,207,331 shares of Stryker common stock. This figure appears in the Form 4 as the amount of securities beneficially owned following the final listed sale by the revocable trust.

What additional indirect Stryker (SYK) holdings are reported in this Form 4?

Beyond the revocable trust, the Form 4 reports 13,578,805 Stryker shares held indirectly by the L. Lee Stryker Trust and 37,600 shares held indirectly by the 1988 William D. Johnston Trust. It also notes 560 Stryker shares held directly in the reporting person’s name.

Who is the reporting person in this Stryker Form 4 filing?

The reporting person is Ronda E. Stryker, identified as a director of Stryker Corporation. The filing indicates that many of the reported transactions and holdings are indirect, including positions held by a revocable trust and other named trusts associated with her.

What does the Form 4 say about how the Stryker shares were sold?

The Form 4 explains that each reported price is a weighted average sale price for multiple trades. For each transaction line, the filing lists a price range and notes that detailed trade-by-trade pricing is available upon request from the company, regulators, or shareholders.
Stryker Corp

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

138.60B
361.53M
5.36%
81.68%
1.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE